Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line
- PMID: 28497345
- DOI: 10.1007/s11064-017-2292-y
Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line
Abstract
Retinoids (vitamin A and derivatives) are recognized as essential factors for central nervous system (CNS) development. Retinol (vitamin A) also was postulated to be a major antioxidant component of diet as it modulates reactive species (RS) production and oxidative stress in biological systems. Oxidative stress plays a major role either in pathogenesis or development of neurodegenerative diseases, or even in both. Here we investigate the role of retinol supplementation to human neuron-derived SH-SY5Y cells over RS production and biochemical markers associated to neurodegenerative diseases expressed at neuronal level in Parkinson's disease and Alzheimer's disease: α-synuclein, β-amyloid peptide, tau phosphorylation and RAGE. Retinol treatment (24 h) impaired cell viability and increased intracellular RS production at the highest concentrations (7 up to 20 µM). Antioxidant co-treatment (Trolox 100 µM) rescued cell viability and inhibited RS production. Furthermore, retinol (10 µM) increased the levels of α-synuclein, tau phosphorylation at Ser396, β-amyloid peptide and RAGE. Co-treatment with antioxidant Trolox inhibited the increased in RAGE, but not the effect of retinol on α-synuclein, tau phosphorylation and β-amyloid peptide accumulation. These data indicate that increased availability of retinol to neurons at levels above the cellular physiological concentrations may induce deleterious effects through diverse mechanisms, which include oxidative stress but also include RS-independent modulation of proteins associated to progression of neuronal cell death during the course of neurodegenerative diseases.
Keywords: Neurodegeneration; Neurotoxicity; Oxidative stress; RAGE; SH-SY5Y; Vitamin A.
Similar articles
-
Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells.Cell Signal. 2013 Apr;25(4):939-54. doi: 10.1016/j.cellsig.2013.01.013. Epub 2013 Jan 16. Cell Signal. 2013. PMID: 23333461
-
Vitamin A (retinol) up-regulates the receptor for advanced glycation endproducts (RAGE) through p38 and Akt oxidant-dependent activation.Toxicology. 2011 Oct 28;289(1):38-44. doi: 10.1016/j.tox.2011.07.008. Epub 2011 Jul 23. Toxicology. 2011. PMID: 21807062
-
Retinol up-regulates the receptor for advanced glycation endproducts (RAGE) by increasing intracellular reactive species.Toxicol In Vitro. 2008 Aug;22(5):1123-7. doi: 10.1016/j.tiv.2008.02.016. Epub 2008 Mar 5. Toxicol In Vitro. 2008. PMID: 18396385
-
A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases.Rev Med Chir Soc Med Nat Iasi. 2014 Jan-Mar;118(1):19-27. Rev Med Chir Soc Med Nat Iasi. 2014. PMID: 24741770 Review.
-
Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.J Alzheimers Dis. 2011;24 Suppl 2:223-32. doi: 10.3233/JAD-2011-110182. J Alzheimers Dis. 2011. PMID: 21460436 Review.
Cited by
-
Exploring the Role of Reactive Oxygen Species in the Pathogenesis and Pathophysiology of Alzheimer's and Parkinson's Disease and the Efficacy of Antioxidant Treatment.Antioxidants (Basel). 2024 Sep 20;13(9):1138. doi: 10.3390/antiox13091138. Antioxidants (Basel). 2024. PMID: 39334797 Free PMC article. Review.
-
Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease.Oxid Med Cell Longev. 2019 Jan 17;2019:8165707. doi: 10.1155/2019/8165707. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 30800211 Free PMC article. Review.
-
Neuroprotective Effect of Epalrestat on Hydrogen Peroxide-Induced Neurodegeneration in SH-SY5Y Cellular Model.J Microbiol Biotechnol. 2021 Jun 28;31(6):867-874. doi: 10.4014/jmb.2101.01002. J Microbiol Biotechnol. 2021. PMID: 33820886 Free PMC article.
-
Could Vitamins Have a Positive Impact on the Treatment of Parkinson's Disease?Brain Sci. 2023 Feb 6;13(2):272. doi: 10.3390/brainsci13020272. Brain Sci. 2023. PMID: 36831815 Free PMC article. Review.
-
Potential benefits of vitamin A and its derivatives in glaucoma.Eur J Med Res. 2025 Jul 1;30(1):527. doi: 10.1186/s40001-025-02780-4. Eur J Med Res. 2025. PMID: 40597446 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
- 401260/2014-3/Conselho Nacional de Desenvolvimento Científico e Tecnológico/International
- 400437/2013-9/Conselho Nacional de Desenvolvimento Científico e Tecnológico/International
- 401368/2012-2/Conselho Nacional de Desenvolvimento Científico e Tecnológico/International
- 303227/2015-0/Conselho Nacional de Desenvolvimento Científico e Tecnológico/International
- 443514/2014-3/Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical